CD8A and cancer: Pan-cancer analyses demonstrate that elevated m5C levels correlate with enhanced expression of CXCL10 and CCL5, improving CD8+ T-cell infiltration and sensitizing otherwise “cold” tumors to checkpoint blockade (6).